Legal Representation
Attorney
PAUL A MAHON
USPTO Deadlines
Application History
15 events| Date | Code | Type | Description |
|---|---|---|---|
| May 8, 2001 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Aug 4, 2000 | DPCC | D | DIVISIONAL PROCESSING COMPLETE |
| Aug 2, 2000 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jun 13, 2000 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jan 21, 2000 | DRRR | I | DIVISIONAL REQUEST RECEIVED |
| Dec 21, 1999 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Sep 28, 1999 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 27, 1999 | NPUB | O | NOTICE OF PUBLICATION |
| Jun 19, 1999 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| May 20, 1999 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 15, 1999 | CNSL | F | LETTER OF SUSPENSION MAILED |
| Mar 8, 1999 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sep 22, 1998 | CNSL | F | LETTER OF SUSPENSION MAILED |
| Sep 4, 1998 | CNEA | F | EXAMINER'S AMENDMENT MAILED |
| Aug 10, 1998 | DOCK | D | ASSIGNED TO EXAMINER |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of chronic conditions, namely, chronic liver disease, chronic central nervous system disease, chronic gastroenterological disease, metastatic cancer and chronic respiratory disease
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
medical services, namely, development and implementation of medical therapies for different chronic conditions and diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"